Guest post by Mark Silk, who is filling in for Steven Waldman.
In his order reversing the Bush administration’s restrictions on federal funding of stem cell research earlier this month, President Obama received some undeserved criticism for minimizing the role of moral values in shaping science policy. Yes he did, in his signing statement, insist that promoting science “is about ensuring that scientific data is never distorted or concealed to serve a political agenda–and that we make scientific decisions based on facts, not ideology.” But this came after his citing of the “difficult and delicate balance” involved, the moral objections of “thoughtful and decent people,” and the evident public consensus in favor of stem cell research. The president was not suggesting that science is just about facts separated from values.
Plaintiffs have presented unrebutted evidence of the FDA’s lack of good faith regarding its decisions on the Plan B switch applications. This lack of good faith is evidenced by, among other things, (1) repeated and unreasonable delays, pressure emanating from the White House, and the obvious connection between the confirmation process of two FDA Commissioners and the timing of the FDA’s decisions; and (2) significant departures from the FDA’s normal procedures and policies in the review of the Plan B switch applications as compared to the review of other switch applications in the past 10 years.
Check out Mark Silk’s blog, Spiritual Politics.